These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 20209122

  • 41. Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.
    Tran CT, Fox MF, Vallance P, Leiper JM.
    Genomics; 2000 Aug 15; 68(1):101-5. PubMed ID: 10950934
    [Abstract] [Full Text] [Related]

  • 42. Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood.
    Hannemann J, Zummack J, Hillig J, Rendant-Gantzberg L, Böger R.
    J Clin Med; 2022 Feb 11; 11(4):. PubMed ID: 35207213
    [Abstract] [Full Text] [Related]

  • 43. Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.
    Caplin B, Nitsch D, Gill H, Hoefield R, Blackwell S, MacKenzie D, Cooper JA, Middleton RJ, Talmud PJ, Veitch P, Norman J, Wheeler DC, Leiper JM.
    Kidney Int; 2010 Mar 11; 77(5):459-67. PubMed ID: 20010544
    [Abstract] [Full Text] [Related]

  • 44. Pilot study of the association of the DDAH2 -449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis.
    Weiss SL, Yu M, Jennings L, Haymond S, Zhang G, Wainwright MS.
    PLoS One; 2012 Mar 11; 7(3):e33355. PubMed ID: 22428028
    [Abstract] [Full Text] [Related]

  • 45. Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis.
    Chertow JH, Alkaitis MS, Nardone G, Ikeda AK, Cunnington AJ, Okebe J, Ebonyi AO, Njie M, Correa S, Jayasooriya S, Casals-Pascual C, Billker O, Conway DJ, Walther M, Ackerman H.
    PLoS Pathog; 2015 Sep 11; 11(9):e1005119. PubMed ID: 26407009
    [Abstract] [Full Text] [Related]

  • 46. The iridoid loganic acid and anthocyanins from the cornelian cherry (Cornus mas L.) fruit increase the plasma l-arginine/ADMA ratio and decrease levels of ADMA in rabbits fed a high-cholesterol diet.
    Sozański T, Kucharska AZ, Wiśniewski J, Fleszar MG, Rapak A, Gomułkiewicz A, Dzięgiel P, Magdalan J, Nowak B, Szumny D, Matuszewska A, Piórecki N, Szeląg A, Trocha M.
    Phytomedicine; 2019 Jan 11; 52():1-11. PubMed ID: 30599888
    [Abstract] [Full Text] [Related]

  • 47. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
    Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P, Klepetko W, Aigner C, Fink L, Muyal JP, Weissmann N, Grimminger F, Seeger W, Schermuly RT.
    FASEB J; 2005 Jul 11; 19(9):1175-7. PubMed ID: 15827267
    [Abstract] [Full Text] [Related]

  • 48. A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia.
    Trittmann JK, Gastier-Foster JM, Zmuda EJ, Frick J, Rogers LK, Vieland VJ, Chicoine LG, Nelin LD.
    Acta Paediatr; 2016 Apr 11; 105(4):e170-5. PubMed ID: 26663142
    [Abstract] [Full Text] [Related]

  • 49. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Xiong Y, Lei M, Fu S, Fu Y.
    Life Sci; 2005 May 27; 77(2):149-59. PubMed ID: 15862600
    [Abstract] [Full Text] [Related]

  • 50. Abnormalities of the PRMT1-ADMA-DDAH1 metabolism axis and probucol treatment in diabetic patients and diabetic rats.
    Mei X, Zeng J, Liu DF, Zhao Y, Yang HL, Li Y, Qiu P, Tang MW.
    Ann Palliat Med; 2021 Mar 27; 10(3):3343-3353. PubMed ID: 33849119
    [Abstract] [Full Text] [Related]

  • 51. Extensive characterization of the human DDAH1 transgenic mice.
    Schwedhelm E, von Leitner EC, Atzler D, Schmitz C, Jacobi J, Meinertz T, Münzel T, Baldus S, Cooke JP, Böger RH, Maas R, Sydow K.
    Pharmacol Res; 2009 Dec 27; 60(6):494-502. PubMed ID: 19666120
    [Abstract] [Full Text] [Related]

  • 52. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X, Zhang P, Kwak D, Fassett J, Yue W, Atzler D, Hu X, Liu X, Wang H, Lu Z, Guo H, Schwedhelm E, Böger RH, Chen P, Chen Y.
    Basic Res Cardiol; 2017 Aug 17; 112(5):55. PubMed ID: 28819685
    [Abstract] [Full Text] [Related]

  • 53. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
    Garbin U, Pasini AF, Stranieri C, Manfro S, Boccioletti V, Cominacini L.
    Pharmacol Res; 2007 Dec 17; 56(6):515-21. PubMed ID: 17977009
    [Abstract] [Full Text] [Related]

  • 54. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
    Tomlinson JA, Caplin B, Boruc O, Bruce-Cobbold C, Cutillas P, Dormann D, Faull P, Grossman RC, Khadayate S, Mas VR, Nitsch DD, Wang Z, Norman JT, Wilcox CS, Wheeler DC, Leiper J.
    J Am Soc Nephrol; 2015 Dec 17; 26(12):3045-59. PubMed ID: 25855779
    [Abstract] [Full Text] [Related]

  • 55. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.
    Andreozzi F, Presta I, Mannino GC, Scarpelli D, Di Silvestre S, Di Pietro N, Succurro E, Sciacqua A, Pandolfi A, Consoli A, Hribal ML, Perticone F, Sesti G.
    PLoS One; 2012 Dec 17; 7(4):e36224. PubMed ID: 22558392
    [Abstract] [Full Text] [Related]

  • 56. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A, Zhao Y, Warren JS.
    Nephrol Dial Transplant; 2008 May 17; 23(5):1513-20. PubMed ID: 18204093
    [Abstract] [Full Text] [Related]

  • 57. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF, Garbin U, Stranieri C, Boccioletti V, Mozzini C, Manfro S, Pasini A, Cominacini M, Cominacini L.
    Am J Hypertens; 2008 Nov 17; 21(11):1251-7. PubMed ID: 18772860
    [Abstract] [Full Text] [Related]

  • 58. DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts.
    Zhao C, Li T, Han B, Yue W, Shi L, Wang H, Guo Y, Lu Z.
    Free Radic Biol Med; 2016 Mar 17; 92():50-60. PubMed ID: 26806551
    [Abstract] [Full Text] [Related]

  • 59. Haplotypic association of DDAH1 with susceptibility to pre-eclampsia.
    Akbar F, Heinonen S, Pirskanen M, Uimari P, Tuomainen TP, Salonen JT.
    Mol Hum Reprod; 2005 Jan 17; 11(1):73-7. PubMed ID: 15501905
    [Abstract] [Full Text] [Related]

  • 60. Markers of nitric oxide are associated with sepsis severity: an observational study.
    Winkler MS, Kluge S, Holzmann M, Moritz E, Robbe L, Bauer A, Zahrte C, Priefler M, Schwedhelm E, Böger RH, Goetz AE, Nierhaus A, Zoellner C.
    Crit Care; 2017 Jul 15; 21(1):189. PubMed ID: 28709458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.